Cargando…

Cryptotanshinone Protects against PCOS-Induced Damage of Ovarian Tissue via Regulating Oxidative Stress, Mitochondrial Membrane Potential, Inflammation, and Apoptosis via Regulating Ferroptosis

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of childbearing age. Cryptotanshinone (CRY) has been shown to be effective in reversing reproductive disorders, but whether it can be used in the treatment of polycystic ovary syndrome remains unclear. We aimed to explor...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Honglin, Xie, Jiani, Fan, Limin, Xia, Yue, Peng, Xia, Zhou, Jianhua, Ni, Xiaorong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001078/
https://www.ncbi.nlm.nih.gov/pubmed/35419170
http://dx.doi.org/10.1155/2022/8011850
_version_ 1784685586933612544
author Liu, Honglin
Xie, Jiani
Fan, Limin
Xia, Yue
Peng, Xia
Zhou, Jianhua
Ni, Xiaorong
author_facet Liu, Honglin
Xie, Jiani
Fan, Limin
Xia, Yue
Peng, Xia
Zhou, Jianhua
Ni, Xiaorong
author_sort Liu, Honglin
collection PubMed
description Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of childbearing age. Cryptotanshinone (CRY) has been shown to be effective in reversing reproductive disorders, but whether it can be used in the treatment of polycystic ovary syndrome remains unclear. We aimed to explore whether the mechanism of cryptotanshinone (CRY) in the treatment of polycystic ovary syndrome (PCOS) can be driven via regulating ferroptosis. A rat model of PCOS was established by daily injection of human chorionic gonadotropin and insulin for 22 days. An in vitro model of ischemia-reperfusion (IR) of granulosa cells was established. The in vitro and rat models of PCOS were subjected to different treatments including ferroptosis activators and inhibitors, CRY, and MAPK inhibitor. Oxidative stress was evaluated by measuring the activities of SOD, MDA, and GSH-PX. Total body weight and ovarian weight, as well as the levels of LH and the LH to FSH ratio, significantly increased in rats with PCOS, compared with controls. The expression of Bax was increased in PCOS tissues while PGC1α, NFR1, GPX4, catalase p-ERK, and Bcl-2 were all downregulated. Ferroptosis activator, erastin, had effects similar to those of PCOS while the contrary was found with CRY and ferroptosis inhibitor treatment groups. In vitro, CRY inhibited oxidative stress, MMP, and NF-κB and activated MAPK/ERK signaling by regulating ferroptosis. Overall, this study indicated that CRY protects against PCOS-induced damage of the ovarian tissue, via regulating oxidative stress, MMP, inflammation, and apoptosis via regulating ferroptosis.
format Online
Article
Text
id pubmed-9001078
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-90010782022-04-12 Cryptotanshinone Protects against PCOS-Induced Damage of Ovarian Tissue via Regulating Oxidative Stress, Mitochondrial Membrane Potential, Inflammation, and Apoptosis via Regulating Ferroptosis Liu, Honglin Xie, Jiani Fan, Limin Xia, Yue Peng, Xia Zhou, Jianhua Ni, Xiaorong Oxid Med Cell Longev Research Article Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of childbearing age. Cryptotanshinone (CRY) has been shown to be effective in reversing reproductive disorders, but whether it can be used in the treatment of polycystic ovary syndrome remains unclear. We aimed to explore whether the mechanism of cryptotanshinone (CRY) in the treatment of polycystic ovary syndrome (PCOS) can be driven via regulating ferroptosis. A rat model of PCOS was established by daily injection of human chorionic gonadotropin and insulin for 22 days. An in vitro model of ischemia-reperfusion (IR) of granulosa cells was established. The in vitro and rat models of PCOS were subjected to different treatments including ferroptosis activators and inhibitors, CRY, and MAPK inhibitor. Oxidative stress was evaluated by measuring the activities of SOD, MDA, and GSH-PX. Total body weight and ovarian weight, as well as the levels of LH and the LH to FSH ratio, significantly increased in rats with PCOS, compared with controls. The expression of Bax was increased in PCOS tissues while PGC1α, NFR1, GPX4, catalase p-ERK, and Bcl-2 were all downregulated. Ferroptosis activator, erastin, had effects similar to those of PCOS while the contrary was found with CRY and ferroptosis inhibitor treatment groups. In vitro, CRY inhibited oxidative stress, MMP, and NF-κB and activated MAPK/ERK signaling by regulating ferroptosis. Overall, this study indicated that CRY protects against PCOS-induced damage of the ovarian tissue, via regulating oxidative stress, MMP, inflammation, and apoptosis via regulating ferroptosis. Hindawi 2022-04-04 /pmc/articles/PMC9001078/ /pubmed/35419170 http://dx.doi.org/10.1155/2022/8011850 Text en Copyright © 2022 Honglin Liu et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Liu, Honglin
Xie, Jiani
Fan, Limin
Xia, Yue
Peng, Xia
Zhou, Jianhua
Ni, Xiaorong
Cryptotanshinone Protects against PCOS-Induced Damage of Ovarian Tissue via Regulating Oxidative Stress, Mitochondrial Membrane Potential, Inflammation, and Apoptosis via Regulating Ferroptosis
title Cryptotanshinone Protects against PCOS-Induced Damage of Ovarian Tissue via Regulating Oxidative Stress, Mitochondrial Membrane Potential, Inflammation, and Apoptosis via Regulating Ferroptosis
title_full Cryptotanshinone Protects against PCOS-Induced Damage of Ovarian Tissue via Regulating Oxidative Stress, Mitochondrial Membrane Potential, Inflammation, and Apoptosis via Regulating Ferroptosis
title_fullStr Cryptotanshinone Protects against PCOS-Induced Damage of Ovarian Tissue via Regulating Oxidative Stress, Mitochondrial Membrane Potential, Inflammation, and Apoptosis via Regulating Ferroptosis
title_full_unstemmed Cryptotanshinone Protects against PCOS-Induced Damage of Ovarian Tissue via Regulating Oxidative Stress, Mitochondrial Membrane Potential, Inflammation, and Apoptosis via Regulating Ferroptosis
title_short Cryptotanshinone Protects against PCOS-Induced Damage of Ovarian Tissue via Regulating Oxidative Stress, Mitochondrial Membrane Potential, Inflammation, and Apoptosis via Regulating Ferroptosis
title_sort cryptotanshinone protects against pcos-induced damage of ovarian tissue via regulating oxidative stress, mitochondrial membrane potential, inflammation, and apoptosis via regulating ferroptosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001078/
https://www.ncbi.nlm.nih.gov/pubmed/35419170
http://dx.doi.org/10.1155/2022/8011850
work_keys_str_mv AT liuhonglin cryptotanshinoneprotectsagainstpcosinduceddamageofovariantissueviaregulatingoxidativestressmitochondrialmembranepotentialinflammationandapoptosisviaregulatingferroptosis
AT xiejiani cryptotanshinoneprotectsagainstpcosinduceddamageofovariantissueviaregulatingoxidativestressmitochondrialmembranepotentialinflammationandapoptosisviaregulatingferroptosis
AT fanlimin cryptotanshinoneprotectsagainstpcosinduceddamageofovariantissueviaregulatingoxidativestressmitochondrialmembranepotentialinflammationandapoptosisviaregulatingferroptosis
AT xiayue cryptotanshinoneprotectsagainstpcosinduceddamageofovariantissueviaregulatingoxidativestressmitochondrialmembranepotentialinflammationandapoptosisviaregulatingferroptosis
AT pengxia cryptotanshinoneprotectsagainstpcosinduceddamageofovariantissueviaregulatingoxidativestressmitochondrialmembranepotentialinflammationandapoptosisviaregulatingferroptosis
AT zhoujianhua cryptotanshinoneprotectsagainstpcosinduceddamageofovariantissueviaregulatingoxidativestressmitochondrialmembranepotentialinflammationandapoptosisviaregulatingferroptosis
AT nixiaorong cryptotanshinoneprotectsagainstpcosinduceddamageofovariantissueviaregulatingoxidativestressmitochondrialmembranepotentialinflammationandapoptosisviaregulatingferroptosis